3/10/23 13:34 | 3/10/23 | CMPX | Compass Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schuetz Thomas J. | MA | DO | CEO | P | 34 | 3.37 | 0 | 10 | 0 | 6,022 | D | | | | | | | | | | | | | | |
2/27/23 11:39 | 2/27/23 | CMPX | Compass Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schuetz Thomas J. | MA | DO | CEO | P | 80 | 3.98 | 0 | 20 | 0 | 6,012 | D | | | | | | | | | | | | | | |
2/15/23 10:47 | 2/15/23 | CMPX | Compass Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schuetz Thomas J. | MA | DO | CEO | P | 77 | 3.86 | 0 | 20 | 0 | 5,992 | D | | | | | | | | | | | | | | |
1/31/23 10:14 | 1/31/23 | CMPX | Compass Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schuetz Thomas J. | MA | DO | CEO | P | 81 | 4.05 | 0 | 20 | 0 | 5,472 | D | | | | | | | | | | | | | | |
1/24/23 10:49 | 1/24/23 | CMPX | Compass Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schuetz Thomas J. | MA | DO | CEO | P | 84 | 4.19 | 0 | 20 | 0 | 5,452 | D | | | | | | | | | | | | | | |
9/28/22 16:45 | 9/28/22 | CMPX | Compass Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schuetz Thomas J. | MA | DO | CEO | P | 23 | 2.32 | 0 | 10 | 0 | 5,432 | D | | | | | | | | | | | | | | |
9/27/22 09:47 | 9/26/22 | CMPX | Compass Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schuetz Thomas J. | MA | DO | CEO | P | 34 | 2.27 | 0 | 15 | 0 | 5,422 | D | | | | | | | | | | | | | | |
9/8/22 10:12 | 9/7/22 | CMPX | Compass Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schuetz Thomas J. | MA | DO | CEO | P | 45 | 3.03 | 0 | 15 | 0 | 5,407 | D | | | | | | | | | | | | | | |
9/1/22 14:37 | 9/1/22 | CMPX | Compass Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schuetz Thomas J. | MA | DO | CEO | P | 42 | 2.83 | 0 | 15 | 0 | 5,392 | D | | | | | | | | | | | | | | |
8/17/22 16:06 | 8/17/22 | CMPX | Compass Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schuetz Thomas J. | MA | DO | CEO | P | 46 | 3.05 | 0 | 15 | 0 | 5,377 | D | | | | | | | | | | | | | | |
8/10/22 10:51 | 8/10/22 | CMPX | Compass Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schuetz Thomas J. | MA | DO | CEO | P | 40 | 2.64 | 0 | 15 | 0 | 5,362 | D | | | | | | | | | | | | | | |
8/2/22 09:15 | 8/1/22 | CMPX | Compass Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schuetz Thomas J. | MA | DO | CEO | P | 39 | 2.58 | 0 | 15 | 0 | 5,347 | D | | | | | | | | | | | | | | |
6/21/22 13:41 | 6/21/22 | CMPX | Compass Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schuetz Thomas J. | MA | DO | CEO | P | 56 | 2.80 | 0 | 20 | 0 | 5,332 | D | | | | | | | | | | | | | | |
6/17/22 16:46 | 6/16/22 | CMPX | Compass Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schuetz Thomas J. | MA | DO | CEO | P | 47 | 2.34 | 0 | 20 | 0 | 5,312 | D | | | | | | | | | | | | | | |
6/13/22 15:59 | 6/13/22 | CMPX | Compass Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schuetz Thomas J. | MA | DO | CEO | P | 69 | 2.29 | 0 | 30 | 1 | 5,292 | D | | | | | | | | | | | | | | |
6/7/22 11:50 | 6/6/22 | CMPX | Compass Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schuetz Thomas J. | MA | DO | CEO | P | 85 | 2.83 | 0 | 30 | 1 | 5,262 | D | | | | | | | | | | | | | | |
6/1/22 12:33 | 6/1/22 | CMPX | Compass Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schuetz Thomas J. | MA | DO | CEO | P | 61 | 3.03 | 0 | 20 | 0 | 5,232 | D | | | | | | | | | | | | | | |
5/26/22 14:58 | 5/26/22 | CMPX | Compass Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schuetz Thomas J. | MA | DO | CEO | P | 61 | 3.04 | 0 | 20 | 0 | 5,212 | D | | | | | | | | | | | | | | |
5/24/22 08:09 | 5/23/22 | CMPX | Compass Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schuetz Thomas J. | MA | DO | CEO | P | 50 | 2.72 | 0 | 18 | 0 | 5,192 | D | | | | | | | | | | | | | | |
5/17/22 15:17 | 5/17/22 | CMPX | Compass Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schuetz Thomas J. | MA | DO | CEO | P | 50 | 2.47 | 0 | 20 | 0 | 5,174 | D | | | | | | | | | | | | | | |
5/10/22 14:15 | 5/10/22 | CMPX | Compass Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Schuetz Thomas J. | MA | DO | CEO | P | 50 | 1.80 | 0 | 28 | 1 | 5,153 | D | | | | | | | | | | | | | | |
3/16/16 19:26 | 3/15/16 | RLYP | Relypsa Inc | | Health | Drug | Pharmaceutical Preparations | Schuetz Thomas J. | CA | D | | P | 402 | 13.39 | 33 | 30 | 757 | 34 | D | -70 | -68 | -48 | -52 | -29 | -23 | -7 | -2 | 12 | 14 | 77 | 56 | | |
6/15/15 18:39 | 6/11/15 | RLYP | Relypsa Inc | | Health | Drug | Pharmaceutical Preparations | Schuetz Thomas J. | CA | D | | S | -35 | 34.57 | 13 | -1 | -20 | 4 | D | | 44 | 7 | -16 | 12 | -1 | -4 | -3 | 0 | -1 | -6 | -28 | -18 | -43 |